Loss of inhibitory insulin receptor substrate-1 phosphorylation is an early event in mammalian target of rapamycin-dependent endometrial hyperplasia and carcinoma.

Loss of inhibitory insulin receptor substrate-1 phosphorylation is an early event in mammalian target of rapamycin-dependent endometrial hyperplasia and carcinoma.

Item
http://www.wikidata.org/entity/Q33918399
Rapamycin extends murine lifespan but has limited effects on aging.The search continues: looking for predictive biomarkers for response to mammalian target of rapamycin inhibition in endometrial cancerLongevity, aging and rapamycin.Morphoproteomic analysis reveals an overexpressed and constitutively activated phospholipase D1-mTORC2 pathway in endometrial carcinomaAltered gene expression patterns during the initiation and promotion stages of neonatally diethylstilbestrol-induced hyperplasia/dysplasia/neoplasia in the hamster uterus.Rapamycin and mTORC1 inhibition in the mouse: skin cancer prevention.Personalized therapy in endometrial cancer: challenges and opportunities.Clinical assessment of PTEN loss in endometrial carcinoma: immunohistochemistry outperforms gene sequencing.MicroRNA-126 inhibits the migration and invasion of endometrial cancer cells by targeting insulin receptor substrate 1IRS2 is a candidate driver oncogene on 13q34 in colorectal cancer.Loss of p27 Associated with Risk for Endometrial Carcinoma Arising in the Setting of Obesity.
P2860

Loss of inhibitory insulin receptor substrate-1 phosphorylation is an early event in mammalian target of rapamycin-dependent endometrial hyperplasia and carcinoma.

Item
http://www.wikidata.org/entity/Q33918399
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Loss of inhibitory insulin rec ...... ial hyperplasia and carcinoma.
@ast
Loss of inhibitory insulin rec ...... ial hyperplasia and carcinoma.
@en
type
label
Loss of inhibitory insulin rec ...... ial hyperplasia and carcinoma.
@ast
Loss of inhibitory insulin rec ...... ial hyperplasia and carcinoma.
@en
prefLabel
Loss of inhibitory insulin rec ...... ial hyperplasia and carcinoma.
@ast
Loss of inhibitory insulin rec ...... ial hyperplasia and carcinoma.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
Loss of inhibitory insulin rec ...... ial hyperplasia and carcinoma.
@en
P2093
P2860
P304
P31
P356
10.1158/1940-6207.CAPR-09-0199
P433
P478
P577
P698
P921
P932